145 related articles for article (PubMed ID: 9031667)
1. Antifungal antibiotic benanomicin A increases susceptibility of Candida albicans to phagocytosis by murine macrophages.
Watabe H; Mikuniya T; Inouye S; Abe S; Yamaguchi H; Kondo S; Takeuchi T; Klein TW; Friedman H; Yamamoto Y
J Antibiot (Tokyo); 1996 Dec; 49(12):1221-5. PubMed ID: 9031667
[TBL] [Abstract][Full Text] [Related]
2. Antifungal antibiotic hamycin increases susceptibility of Candida albicans to phagocytosis by murine macrophages.
Dhuley JN
FEMS Immunol Med Microbiol; 1998 Feb; 20(2):153-7. PubMed ID: 9544783
[TBL] [Abstract][Full Text] [Related]
3. Binding of benanomicin A to fungal cells in reference to its fungicidal action.
Watanabe M; Gomi S; Tohyama H; Ohtsuka K; Shibahara S; Inouye S; Kobayashi H; Suzuki S; Kondo S; Takeuchi T; Yamaguchi H
J Antibiot (Tokyo); 1996 Apr; 49(4):366-73. PubMed ID: 8642000
[TBL] [Abstract][Full Text] [Related]
4. New hydroxybenanomicins produced by Actinomadura.
Kondo S; Gomi S; Uotani K; Miyakawa S; Inouye S; Ikeda D; Takeuchi T
Drugs Exp Clin Res; 1992; 18(6):217-24. PubMed ID: 1478160
[TBL] [Abstract][Full Text] [Related]
5. Graphene oxide nanosheets increase Candida albicans killing by pro-inflammatory and reparative peritoneal macrophages.
Diez-Orejas R; Feito MJ; Cicuéndez M; Casarrubios L; Rojo JM; Portolés MT
Colloids Surf B Biointerfaces; 2018 Nov; 171():250-259. PubMed ID: 30036792
[TBL] [Abstract][Full Text] [Related]
6. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
[TBL] [Abstract][Full Text] [Related]
7. Morphological alterations of Saccharomyces cerevisiae induced by benanomicin A, an antifungal antibiotic with mannan affinity.
Watanabe M; Nishiyama Y; Inouye S; Yamaguchi H; Kondo S; Takeuchi T
Microbiol Immunol; 1998; 42(5):365-70. PubMed ID: 9654368
[TBL] [Abstract][Full Text] [Related]
8. Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans.
Hazen KC; Mandell G; Coleman E; Wu G
FEMS Microbiol Lett; 2000 Feb; 183(1):89-94. PubMed ID: 10650207
[TBL] [Abstract][Full Text] [Related]
9. Mode of antifungal action of benanomicin A in Saccharomyces cerevisiae.
Watanabe M; Tohyama H; Hiratani T; Watabe H; Inoue S; Kondo S; Takeuchi T; Yamaguchi H
J Antibiot (Tokyo); 1997 Dec; 50(12):1042-51. PubMed ID: 9510912
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of graphene oxide nanosheets on Candida albicans phagocytosis by murine peritoneal macrophages.
Diez-Orejas R; Feito MJ; Cicuéndez M; Rojo JM; Portolés MT
J Colloid Interface Sci; 2018 Feb; 512():665-673. PubMed ID: 29107917
[TBL] [Abstract][Full Text] [Related]
11. A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages.
Coste A; Linas MD; Cassaing S; Bernad J; Chalmeton S; Séguéla JP; Pipy B
J Antimicrob Chemother; 2002 May; 49(5):731-40. PubMed ID: 12003965
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity of an antifungal antibiotic benanomicin A in comparison with amphotericin B.
Watanabe M; Hiratani T; Uchida K; Ohtsuka K; Watabe H; Inouye S; Kondo S; Takeuchi T; Yamaguchi H
J Antimicrob Chemother; 1996 Dec; 38(6):1073-7. PubMed ID: 9023656
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent anticandidal action of pradimicin A.
Sawada Y; Numata K; Murakami T; Tanimichi H; Yamamoto S; Oki T
J Antibiot (Tokyo); 1990 Jun; 43(6):715-21. PubMed ID: 2199421
[TBL] [Abstract][Full Text] [Related]
14. Mannan-mediated anticandidal activity of BMY-28864, a new water-soluble pradimicin derivative.
Sawada Y; Murakami T; Ueki T; Fukagawa Y; Oki T
J Antibiot (Tokyo); 1991 Jan; 44(1):119-21. PubMed ID: 2001982
[No Abstract] [Full Text] [Related]
15. Interaction of Candida albicans, macrophages and fluconazole: in vitro and ex vivo observations.
Tullio V; Cuffini AM; De Leo C; Perrone F; Carlone NA
J Chemother; 1996 Dec; 8(6):438-44. PubMed ID: 8981184
[TBL] [Abstract][Full Text] [Related]
16. [Macrophage interaction with Candida albicans in immunodepression].
Pakhomova EN; Bykov VL
Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):14-6. PubMed ID: 8184605
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase.
Lefkowitz SS; Gelderman MP; Lefkowitz DL; Moguilevsky N; Bollen A
J Infect Dis; 1996 May; 173(5):1202-7. PubMed ID: 8627073
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages.
Gaziri G; Gaziri LC; Kikuchi R; Scanavacca J; Felipe I
Med Mycol; 1999 Jun; 37(3):195-200. PubMed ID: 10421851
[TBL] [Abstract][Full Text] [Related]
19. Phagocytic and candidacidal activities of macrophages from suckling and adult mice pretreated with concanavalin-A.
Moresco TR; Gaziri LC; Yasumoto Y; Felipe I
Med Mycol; 2002 Aug; 40(4):393-7. PubMed ID: 12230219
[TBL] [Abstract][Full Text] [Related]
20. Concanavalin A enhances phagocytosis and killing of Candida albicans by mice peritoneal neutrophils and macrophages.
Loyola W; Gaziri DA; Gaziri LC; Felipe I
FEMS Immunol Med Microbiol; 2002 Jul; 33(3):201-8. PubMed ID: 12110482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
